HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease.

AbstractAIM:
To determine the role of leptin system in non-alcoholic fatty liver disease (NAFLD) development by delineating the changes in serum levels of leptin and soluble leptin receptor (sOB-R).
METHODS:
Blood samples were collected from 30 consecutive patients with liver-biopsy-proven NAFLD and 30 patients with cholecystolithiasis (stationary phase) as controls. Serum leptin levels were determined by radioimmunoassay and concentration of sOB-R was measured by ELISA. Body mass index (BMI) was calculated for all subjects, and serum insulin, C-peptide, and lipoprotein levels were also detected.
RESULTS:
Mean serum leptin level and BMI in the NAFLD group were significantly higher than in the controls (both P < 0.001), but mean sOB-R level was lower in the NAFLD group when compared to the controls. Both men and women in the NAFLD group had higher mean serum leptin levels and lower sOB-R levels than did the men and women in the control group (all P < 0.001). There was a significant negative correlation between serum leptin and sOB-R levels (r = -0.725, P < 0.001). Multivariate analysis showed that the percentage of hepatocyte steatosis, sex, BMI, and homeostasis model assessment of insulin resistance (HOMA IR) were independently related to serum leptin levels.
CONCLUSION:
Elevated serum leptin seems to be a feature of steatosis, and serum leptin seems to increase as hepatocyte steatosis develops. An enhanced release of leptin is accompanied by an decrease in sOB-R concentration, which suggests higher resistance of peripheral tissues towards the action of leptin.
AuthorsXiao-Dong Huang, Yan Fan, Hen Zhang, Ping Wang, Jing-Ping Yuan, Ming-Jie Li, Xi-Yan Zhan
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 14 Issue 18 Pg. 2888-93 (May 14 2008) ISSN: 1007-9327 [Print] United States
PMID18473416 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • C-Peptide
  • Insulin
  • Leptin
  • Lipoproteins
  • Receptors, Leptin
Topics
  • Adult
  • Biopsy
  • Body Mass Index
  • C-Peptide (blood)
  • Case-Control Studies
  • Fatty Liver (blood, metabolism, pathology)
  • Female
  • Homeostasis
  • Humans
  • Insulin (blood)
  • Leptin (blood)
  • Lipoproteins (blood)
  • Liver (metabolism, pathology)
  • Male
  • Middle Aged
  • Receptors, Leptin (blood)
  • Sex Characteristics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: